Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;36(2):281-283.
doi: 10.1007/s40620-022-01528-1. Epub 2022 Dec 3.

Accuracy of serum PLA2R antibody detected by indirect immunofluorescence in diagnosing biopsy-proven primary membranous nephropathy: a single-center experience and a systematic review of the literature

Affiliations

Accuracy of serum PLA2R antibody detected by indirect immunofluorescence in diagnosing biopsy-proven primary membranous nephropathy: a single-center experience and a systematic review of the literature

Marco Allinovi et al. J Nephrol. 2023 Mar.
No abstract available

Keywords: Enzyme-linked immunosorbent assay; Indirect immunofluorescence assay; Membranous nephropathy; PLA2R-Ab.

PubMed Disclaimer

References

    1. Du Y, Li J, He F et al (2014) The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis. PLoS One 9:e104936 - DOI - PubMed - PMC
    1. Porcelli B, Guarnieri A, Ferretti F et al (2021) Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience. J Nephrol 34:573–579 - DOI - PubMed
    1. Tampoia M, Migliucci F, Villani C et al (2018) Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy. J Nephrol 31:899–905 - DOI - PubMed
    1. Li C, Li P, Guo W et al (2022) The optimal anti-phospholipase A2 receptor cut-off for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study. Korean J Intern Med 37:154–166 - DOI - PubMed
    1. Liu Y, Li X, Ma C et al (2018) Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: the optimal cut-off value for Chinese patients. ClinChimActa 476:9–14

LinkOut - more resources